Expertise in
12
conditions

Dr. Michael Duncan

Intensive Care Medicine
Baylor Scott & White Advanced Heart Failure Clinic-Dallas
3410 Worth St Ste 250, 
Dallas, TX 
Expertise in
12
conditions
Baylor Scott & White Advanced Heart Failure Clinic-Dallas
3410 Worth St Ste 250, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Duncan is an Intensive Care Medicine provider in Dallas, Texas. Dr. Duncan is highly rated in 12 conditions, according to our data. His top areas of expertise are Bronchiolitis Obliterans, Industrial Bronchitis, Idiopathic Pulmonary Fibrosis, Bronchitis, and Lung Transplant.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in IN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 2 Less Insurance Carriers -

Locations

Baylor Scott & White Advanced Heart Failure Clinic-Dallas
3410 Worth St Ste 250, Dallas, TX 75246
Other Locations
IU Health Physicians Pulmonary & Critical Care Medicine
1801 Senate Blvd Ste 230, Indianapolis, IN 46202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2025
Intervention Type: Combination product, Other
Study Drug: Extracorporeal Photopheresis (ECP)
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

8 Total Publications

Post lung-transplant predictive value of thermodilution vs estimated Fick cardiac output measurement.
Post lung-transplant predictive value of thermodilution vs estimated Fick cardiac output measurement.
Journal: JHLT open
Published: March 27, 2025
Similar Doctors
Expertise in
23
conditions
Dr. Traci Adams
Intensive Care Medicine
Expertise in
23
conditions
Dr. Traci Adams
Intensive Care Medicine

Office

5939 Harry Hines Blvd Ste 935, 
Dallas, TX 
 (5.1 miles away)
214-645-6616
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Traci Adams is an Intensive Care Medicine provider in Dallas, Texas. Dr. Adams is highly rated in 23 conditions, according to our data. Her top areas of expertise are Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Endoscopy, and Lung Transplant.

Expertise in
18
conditions
Dr. Craig Glazer
Intensive Care Medicine
Expertise in
18
conditions
Dr. Craig Glazer
Intensive Care Medicine

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (3.9 miles away)
214-645-2867
Languages Spoken:
English
See accepted insurances

Craig Glazer is an Intensive Care Medicine provider in Dallas, Texas. Dr. Glazer is highly rated in 18 conditions, according to our data. His top areas of expertise are Hypersensitivity Pneumonitis, Interstitial Lung Disease, Acute Interstitial Pneumonia, Lung Transplant, and Endoscopy.

Expertise in
10
conditions
Dr. Raksha Jain
Intensive Care Medicine
Expertise in
10
conditions
Dr. Raksha Jain
Intensive Care Medicine

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (3.9 miles away)
214-648-2546
Languages Spoken:
English
See accepted insurances

Raksha Jain is an Intensive Care Medicine provider in Dallas, Texas. Dr. Jain is highly rated in 10 conditions, according to our data. Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Bronchiectasis, and Lung Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Duncan's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile